Amplicore Revenue and Competitors

Claim your profile

Mason, OH USA

Location

$20.7M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Amplicore's estimated annual revenue is currently $1.2M per year.(i)
  • Amplicore's estimated revenue per employee is $100,500
  • Amplicore's total funding is $20.7M.

Employee Data

  • Amplicore has 12 Employees.(i)
  • Amplicore grew their employee count by 33% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3M3620%N/AN/A
#2
$4.8M58-8%N/AN/A
#3
$4.8M24-47%N/AN/A
#4
$1090M462020%$38.4MN/A
#5
$2.6M3129%N/AN/A
#6
$1.2M1233%$20.7MN/A
#7
$4.1M504%N/AN/A
#8
$0.8M860%$67.6MN/A
#9
$25.7M1554%N/AN/A
#10
$6.3M7690%N/AN/A

We develop injectable therapeutics for degenerative musculoskeletal disorders to serve unmet medical needs. Unlike current treatments, we take a regenerative approach to joint osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tear. We are committed to addressing the underlying causes of joint discomfort, in addition to relieving pain. Our mission is to translate scientific innovation into effective but minimally invasive products that can be easily delivered to patients.

keywords:N/A

$20.7M

Total Funding

12

Number of Employees

$1.2M

Revenue (est)

33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Amplicore News

2022-04-06 - Venture Lab-backed startup earns $6 million of funding

Amplicore plans to begin a first clinical trial in 2022 for its solution to treat acute meniscal tears, one of the most common knee injuries.

2021-03-26 - Amplicore Closes $4M Seed Funding

Amplicore Inc., a Cincinnati, OH-based early-stage biopharmaceutical company, closed its $4m seed round of funding. The round was led by Photon Fund, with participation from Industrial Technology Investment Corporation, Berkeley Catalyst Fund, and SVE Capital. Led by Dr. Chia-Ying (James) Lin, ...

2021-03-25 - Amplicore, Inc. Announces Closing of a Successful $4M Seed Funding Round

CINCINNATI, March 25, 2021 /PRNewswire/ -- Amplicore Inc., an early-stage biopharmaceutical company currently developing locally delivered and minimally invasive therapeutic solutions for musculoskeletal diseases, has successfully closed its Series Seed round of funding at $4 million. Investme ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M13117%N/A
#2
$1.8M15N/AN/A
#3
$2.4M200%N/A
#4
$3.5M21-30%N/A
#5
$3.7M2175%N/A